© 2003 by Oxford University Press
© 2003 Oxford University Press
ARTICLE |
Obesity, Tamoxifen Use, and Outcomes in Women With Estrogen Receptor–Positive Early-Stage Breast Cancer
Affiliations of authors: J. J. Dignam, Department of Health Studies and Cancer Research Center, The University of Chicago, Chicago, IL, and National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA; K. Wieand, Department of Health Studies and Cancer Research Center, The University of Chicago; K. A. Johnson, Breast and Gynecologic Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD; B. Fisher, NSABP; L. Xu, Department of Biostatistics, University of Pittsburgh, Pittsburgh; E. P. Mamounas, NSABP and Cancer Center, Aultman Hospital, Canton, OH.
Correspondence to: James J. Dignam, PhD, Department of Health Studies, 5841 South Maryland Ave., MC 2007, The University of Chicago, Chicago, IL 60637 (e-mail: jdignam{at}health.bsd.uchicago.edu).
Background: Obesity is associated with both increased breast cancer risk and poorer prognosis after disease onset. However, little is known about the effect of obesity on treatment efficacy. We evaluated the association of obesity with outcomes and with tamoxifen efficacy in women with early-stage, hormone-responsive breast cancer participating in a multicenter cancer cooperative group clinical trial. Methods: The cohort consisted of 3385 women enrolled in National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol B-14, a randomized, placebo-controlled trial evaluating tamoxifen for lymph node–negative, estrogen receptor (ER)–positive breast cancer. Hazards of breast cancer recurrence, contralateral breast tumors, other new primary cancers, and several mortality endpoints were evaluated in relation to body mass index (BMI), using statistical modeling to adjust for other prognostic factors. Median follow-up time was 166 months. All statistical tests were two-sided. Results: The hazard of breast cancer recurrence was the same among obese (BMI 
30.0 kg/m2) women as compared with underweight and normal-weight women (BMI <25.0; hazard ratio [HR] = 0.98, 95% confidence interval [CI] = 0.80 to 1.18). Contralateral breast cancer hazard was higher in obese women than in underweight/normal-weight women (HR = 1.58, 95% CI = 1.10 to 2.25), as was the risk of other primary cancers (HR = 1.62, 95% CI = 1.16 to 2.24). Compared with normal-weight women, obese women had greater all-cause mortality (HR = 1.31, 95% CI = 1.12 to 1.54) and greater risk of deaths due to causes unrelated to breast cancer (HR = 1.49, 95% CI = 1.15 to 1.92). Breast cancer mortality was not statistically significantly increased for obese women (HR = 1.20, 95% CI = 0.97 to 1.49). Tamoxifen reduced breast cancer recurrence and mortality, regardless of BMI. Conclusions: For women with lymph node–negative, ER-positive breast cancer, obesity was not associated with a material increase in recurrence risk or a change in tamoxifen efficacy. However, because obesity was associated with increased risks of contralateral breast cancer, of other primary cancers, and of overall mortality, it may influence long-term outcomes for breast cancer survivors.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. K. Litton, A. M. Gonzalez-Angulo, C. L. Warneke, A. U. Buzdar, S.-W. Kau, M. Bondy, S. Mahabir, G. N. Hortobagyi, and A. M. Brewster Relationship Between Obesity and Pathologic Response to Neoadjuvant Chemotherapy Among Women With Operable Breast Cancer J. Clin. Oncol., September 1, 2008; 26(25): 4072 - 4077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dawood, K. Broglio, A. M. Gonzalez-Angulo, S.-W. Kau, R. Islam, G. N. Hortobagyi, and M. Cristofanilli Prognostic Value of Body Mass Index in Locally Advanced Breast Cancer Clin. Cancer Res., March 15, 2008; 14(6): 1718 - 1725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Bertelsen, L. Bernstein, J. H. Olsen, L. Mellemkjaer, R. W. Haile, C. F. Lynch, K. E. Malone, H. Anton-Culver, J. Christensen, B. Langholz, et al. Effect of Systemic Adjuvant Treatment on Risk for Contralateral Breast Cancer in the Women's Environment, Cancer and Radiation Epidemiology Study J Natl Cancer Inst, January 2, 2008; 100(1): 32 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S.M. Buist, L. Ichikawa, M. N. Prout, M. U. Yood, T. S. Field, C. Owusu, A. M. Geiger, V. P. Quinn, F. Wei, and R. A. Silliman Receipt of Appropriate Primary Breast Cancer Therapy and Adjuvant Therapy Are Not Associated With Obesity in Older Women With Access to Health Care J. Clin. Oncol., August 10, 2007; 25(23): 3428 - 3436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Reeves, K. Faulkner, F. Modugno, T. A. Hillier, D. C. Bauer, K. E. Ensrud, J. A. Cauley, and for the Study of Osteoporotic Fractures Research G Body Mass Index and Mortality among Older Breast Cancer Survivors in the Study of Osteoporotic Fractures Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1468 - 1473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Demirkan, A. Alacacioglu, and U. Yilmaz Relation of Body Mass Index (BMI) to Disease Free (DFS) and Distant Disease Free Survivals (DDFS) Among Turkish Women with Operable Breast Carcinoma Jpn. J. Clin. Oncol., April 1, 2007; 37(4): 256 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Chlebowski Lifestyle Change Including Dietary Fat Reduction and Breast Cancer Outcome J. Nutr., January 1, 2007; 137(1): 233S - 235S. [Full Text] [PDF]
|
|
|
|
|
|
P. E. Abrahamson, M. D. Gammon, M. J. Lund, E. W. Flagg, P. L. Porter, J. Stevens, C. A. Swanson, L. A. Brinton, J. W. Eley, and R. J. Coates General and Abdominal Obesity and Survival among Young Women with Breast Cancer. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1871 - 1877. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-H. Tao, X.-O. Shu, Z. X. Ruan, Y.-T. Gao, and W. Zheng Association of Overweight with Breast Cancer Survival Am. J. Epidemiol., January 15, 2006; 163(2): 101 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Irwin, A. McTiernan, L. Bernstein, F. D. Gilliland, R. Baumgartner, K. Baumgartner, and R. Ballard-Barbash Relationship of Obesity and Physical Activity with C-Peptide, Leptin, and Insulin-Like Growth Factors in Breast Cancer Survivors Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2881 - 2888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Whiteman, S. D. Hillis, K. M. Curtis, J. A. McDonald, P. A. Wingo, and P. A. Marchbanks Body Mass and Mortality After Breast Cancer Diagnosis Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 2009 - 2014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Loi, R. L. Milne, M. L. Friedlander, M. R.E. McCredie, G. G. Giles, J. L. Hopper, and K.-A. Phillips Obesity and Outcomes in Premenopausal and Postmenopausal Breast Cancer Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1686 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Grunfeld, S. Dhesy-Thind, M. Levine, and for The Steering Committee on Clinical Practice Gu Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update) Can. Med. Assoc. J., May 10, 2005; 172(10): 1319 - 1320. [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Schattner, H. J. Willis, A. Raykher, P. Brown, O. Quesada, B. Scott, and M. Shike Long-Term Enteral Nutrition Facilitates Optimization of Body Weight JPEN J Parenter Enteral Nutr, May 1, 2005; 29(3): 198 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Chlebowski Obesity and Early-Stage Breast Cancer J. Clin. Oncol., March 1, 2005; 23(7): 1345 - 1347. [Full Text] [PDF]
|
|
|
|
|
|
C. H. Kroenke, W. Y. Chen, B. Rosner, and M. D. Holmes Weight, Weight Gain, and Survival After Breast Cancer Diagnosis J. Clin. Oncol., March 1, 2005; 23(7): 1370 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Irwin, A. McTiernan, R. N. Baumgartner, K. B. Baumgartner, L. Bernstein, F. D. Gilliland, and R. Ballard-Barbash Changes in Body Fat and Weight After a Breast Cancer Diagnosis: Influence of Demographic, Prognostic, and Lifestyle Factors J. Clin. Oncol., February 1, 2005; 23(4): 774 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Chlebowski, M. Pettinger, M. L. Stefanick, B. V. Howard, Y. Mossavar-Rahmani, and A. McTiernan Insulin, Physical Activity, and Caloric Intake in Postmenopausal Women: Breast Cancer Implications J. Clin. Oncol., November 15, 2004; 22(22): 4507 - 4513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Enger, J. M. Greif, J. Polikoff, and M. Press Body Weight Correlates With Mortality in Early-Stage Breast Cancer Arch Surg, September 1, 2004; 139(9): 954 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Dignam and E. P. Mamounas Obesity and breast cancer prognosis: an expanding body of evidence Ann. Onc., June 1, 2004; 15(6): 850 - 851. [Full Text] [PDF]
|
|